-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Patients with acute myeloid leukemia who are 70 years and older have a poor prognosis
Patients with acute myeloid leukemia who are 70 years and older have a poor prognosis
A large patient data set study from the European Registry collected data on 3,700 newly diagnosed acute myeloid leukemia patients over 70 years of age
Figure 1: Survival rate based on intensive chemotherapy or HMA treatment
Figure 2: Survival rate of intensive chemotherapy or HMA treatment in a paired population matched by propensity score
Figure 2: Survival rate of intensive chemotherapy or HMA treatment in the paired population matched by propensity score Figure 2: Survival rate of intensive chemotherapy or HMA treatment in the paired population matched by propensity score
Complete remission or complete remission with incomplete hematological recovery were 56.
Complete remission or complete remission with incomplete hematological recovery were 56.
This study is the largest multicenter comparison of the two most commonly used first-line therapies in patients over 70 years of age with AML
This study is the largest multicenter comparison of the two most commonly used first-line therapies in patients over 70 years of age with AML
et al.
Leave a message here
